Vivos Inc (RDGL) — 10-Q Filings

10-Q Filings (6)

• Vivos Inc. Deepens Losses Amidst Strategic India Expansion — Nov 12, 2025 Risk: high
  VIVOS INC (RDGL) reported a net loss of $1,987,503 for the nine months ended September 30, 2025, an increase from a net loss of $1,887,260 in the same period of
• VIVOS INC's Losses Widen Amid R&D Spend, Cash Influx from Equity — Aug 13, 2025 Risk: high
  VIVOS INC (RDGL) reported a net loss of $1,480,209 for the six months ended June 30, 2025, a significant increase from the $1,061,997 net loss in the same perio
• VIVOS INC Files Q1 2025 10-Q — May 9, 2025 Risk: medium
  VIVOS INC filed its 10-Q for the period ending March 31, 2025. The company, formerly known as ADVANCED MEDICAL ISOTOPE Corp, is based in Richland, WA, and opera
• VIVOS INC Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  VIVOS INC filed its 10-Q for the period ending September 30, 2024. The company, formerly known as ADVANCED MEDICAL ISOTOPE Corp, is based in Richland, WA, and o
• VIVOS INC Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  VIVOS INC filed its 10-Q for the period ending June 30, 2024. The company, formerly known as ADVANCED MEDICAL ISOTOPE Corp, is based in Richland, WA, and operat
• VIVOS INC Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  VIVOS INC (RDGL) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Vivos Inc. filed a 10-Q report for the period ending March 31, 2024. The company's

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX